Literature DB >> 14559798

DNA alterations in human aberrant crypt foci and colon cancers by random primed polymerase chain reaction.

Liping Luo1, Biaoru Li, Theresa P Pretlow.   

Abstract

Colon cancers are the result of the accumulation of multiple genetic alterations. To evaluate the role genomic instability plays during tumor development, we compared DNA fingerprints of 44 aberrant crypt foci (ACF; the earliest identified neoplastic lesion in the colon), 23 cancers, and normal crypts generated by random primers with PCR. The PCR products, separated by PAGE and viewed after silver staining, demonstrate altered fingerprints for 23.3% of the ACF and 95.7% of the cancers. In this first study of human ACF with this approach, the finding of altered DNA fingerprints in these microscopic lesions suggests that genomic instability can occur very early in human colon tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14559798

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Genetic alterations of hepatocellular carcinoma by random amplified polymorphic DNA analysis and cloning sequencing of tumor differential DNA fragment.

Authors:  Zhi-Hong Xian; Wen-Ming Cong; Shu-Hui Zhang; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2005-07-14       Impact factor: 5.742

2.  Modulating effect of d-carvone on 1,2-dimethylhydrazine-induced pre-neoplastic lesions, oxidative stress and biotransforming enzymes, in an experimental model of rat colon carcinogenesis.

Authors:  R Vinothkumar; M Sudha; P Viswanathan; J Kabalimoorthy; T Balasubramanian; N Nalini
Journal:  Cell Prolif       Date:  2013-09-30       Impact factor: 6.831

3.  Carcinogens induce genome-wide loss of heterozygosity in normal stem cells without persistent chromosomal instability.

Authors:  Sarah L Donahue; Qing Lin; Shang Cao; H Earl Ruley
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

Review 4.  Aberrant crypt foci as precursors in colorectal cancer progression.

Authors:  Frank A Orlando; Dongfeng Tan; Juan D Baltodano; Thaer Khoury; John F Gibbs; Victor J Hassid; Bestoun H Ahmed; Sadir J Alrawi
Journal:  J Surg Oncol       Date:  2008-09-01       Impact factor: 3.454

5.  Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction.

Authors:  S Chariyalertsak; T Khuhaprema; V Bhudisawasdi; B Sripa; S Wongkham; S Petmitr
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-15       Impact factor: 4.322

6.  Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis.

Authors:  Claire M Payne; Carol Bernstein; Katerina Dvorak; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2008-12-16

7.  Identification of novel genetic alterations in samples of malignant glioma patients.

Authors:  Vedrana Milinkovic; Jasna Bankovic; Miodrag Rakic; Tijana Stankovic; Milica Skender-Gazibara; Sabera Ruzdijic; Nikola Tanic
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  Targeting loss of heterozygosity for cancer-specific immunotherapy.

Authors:  Michael S Hwang; Brian J Mog; Jacqueline Douglass; Alexander H Pearlman; Emily Han-Chung Hsiue; Suman Paul; Sarah R DiNapoli; Maximilian F Konig; Drew M Pardoll; Sandra B Gabelli; Chetan Bettegowda; Nickolas Papadopoulos; Bert Vogelstein; Shibin Zhou; Kenneth W Kinzler
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

9.  Feeding of soy protein isolate to rats during pregnancy and lactation suppresses formation of aberrant crypt foci in their progeny's colons: interaction of diet with fetal alcohol exposure.

Authors:  Amanda L Linz; Rijin Xiao; James G Parker; Pippa M Simpson; Thomas M Badger; Frank A Simmen
Journal:  J Carcinog       Date:  2004-10-15

10.  Evaluation of chemopreventive potential of Strobilanthes crispus against colon cancer formation in vitro and in vivo.

Authors:  Nawal Al-Henhena; Shaden A M Khalifa; Rozaida Poh Yuen Ying; Salmah Ismail; Riad Hamadi; Abdrabu N Shawter; Azila Mohd Idris; Ainnul Azizan; Nahla Saeed Al-Wajeeh; Mahmood Ameen Abdulla; Hesham R El-Seedi
Journal:  BMC Complement Altern Med       Date:  2015-11-25       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.